Candriam Equities L Biotech.R USD Acc/ LU0942225912 /
NAV02/05/2024 | Chg.+7.3200 | Type de rendement | Focus sur l'investissement | Société de fonds |
---|---|---|---|---|
260.3500USD | +2.89% | reinvestment | Equity Worldwide | Candriam ▶ |
Performance mensuelle
janv. | févr. | mars | avr. | mai | juin | juil. | août | sept. | oct. | nov. | déc. | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2013 | - | - | - | - | - | - | - | - | - | - | - | 1.68 | - |
2014 | 8.32 | 7.40 | -9.88 | -5.03 | 2.83 | 10.18 | -3.18 | 11.14 | -1.05 | 9.67 | 3.04 | 0.65 | +36.60% |
2015 | 4.53 | 4.60 | 1.93 | -5.05 | 10.81 | 0.70 | 4.23 | -10.89 | -11.33 | 7.88 | 3.49 | 0.39 | +9.00% |
2016 | -23.19 | -4.52 | 3.75 | 3.75 | 5.66 | -8.35 | 12.63 | -2.32 | 4.04 | -12.67 | 9.19 | -2.77 | -18.88% |
2017 | 5.58 | 6.90 | 0.16 | 1.14 | -2.88 | 9.44 | 2.46 | 6.89 | 0.96 | -6.54 | 0.19 | 1.52 | +27.71% |
2018 | 6.76 | -4.56 | -2.08 | -3.16 | 4.67 | 0.87 | 4.47 | 4.19 | -2.05 | -13.96 | 4.19 | -8.27 | -10.56% |
2019 | 13.20 | 3.62 | -0.50 | -4.89 | -4.42 | 9.49 | -2.14 | -2.31 | -4.46 | 11.26 | 12.03 | 2.85 | +36.03% |
2020 | -5.22 | -1.47 | -4.93 | 12.42 | 9.55 | 1.34 | -2.95 | 0.90 | 0.77 | -2.60 | 9.52 | 3.04 | +20.18% |
2021 | 1.87 | -2.55 | -4.22 | 2.77 | -2.21 | 6.41 | -1.41 | 3.95 | -4.19 | 0.21 | -4.33 | 2.46 | -1.91% |
2022 | -10.53 | -1.50 | 6.10 | -7.18 | -3.92 | 3.56 | 4.77 | 1.59 | -1.85 | 6.56 | 6.24 | -2.81 | -0.72% |
2023 | 2.98 | -5.61 | 0.31 | 2.33 | -0.88 | 1.49 | -0.51 | -0.16 | -4.43 | -6.06 | 6.23 | 13.70 | +8.10% |
2024 | 1.56 | 1.41 | 0.03 | -6.18 | 2.89 | - | - | - | - | - | - | - | - |
Valeurs calculées
CAD | 6 Mois | 1 An | 3 Ans | 5 Ans | |
---|---|---|---|---|---|
Volatilité | 16.36% | 18.44% | 16.30% | 20.20% | 22.76% |
Ratio de Sharpe | -0.34 | 1.85 | 0.24 | -0.07 | 0.23 |
Le meilleur mois | +13.70% | +13.70% | +13.70% | +13.70% | +13.70% |
Le plus défavorable mois | -6.18% | -6.18% | -6.18% | -10.53% | -10.53% |
Perte maximale | -10.94% | -10.94% | -15.51% | -28.43% | -29.90% |
Surperformance | -3.63% | - | -4.64% | +3.57% | +0.83% |
Toutes les cotations dans USD
Tranches
Nom | Type de rendement | Prix de rachat | 1 An | 3 Ans | |
---|---|---|---|---|---|
Candriam Equities L Biotechnolog... | reinvestment | 2,005.2800 | +7.40% | +5.34% | |
Candriam Equities L Biotech.C EU... | reinvestment | 217.3000 | +9.72% | - | |
Candriam Equities L Biotech.I-H ... | reinvestment | 2,010.0900 | +5.01% | -2.02% | |
Candriam Equities L Biotech.I EU... | reinvestment | 2,188.1899 | +10.22% | +18.62% | |
Candriam Equities L Biotech.I GB... | reinvestment | 3,369.9399 | +7.08% | +15.89% | |
Candriam Equities L Biotech.R GB... | reinvestment | 353.9900 | +7.59% | +19.68% | |
Candriam Equities L Biotech.R EU... | reinvestment | 320.4600 | +10.74% | +21.20% | |
Candriam Equities L Biotech.R-H ... | reinvestment | 196.3100 | +3.02% | -3.36% | |
Candriam Equities L Biotech.V2 U... | reinvestment | 1,795.9900 | +8.08% | +8.09% | |
Candriam Equities L Biotech.N-H ... | reinvestment | 145.7800 | - | - | |
Candriam Equities L Biotech.N US... | reinvestment | 584.4100 | +6.48% | +3.36% | |
Candriam Equities L Biotech.I US... | reinvestment | 5,486.2402 | +7.27% | +4.95% | |
Candriam Equities L Biotech.C-H ... | reinvestment | 192.5500 | +4.61% | -2.32% | |
Candriam Equities L Biotech.R-H ... | reinvestment | 200.6900 | +5.50% | +0.08% | |
Candriam Equities L Biotech.R US... | reinvestment | 260.3500 | +7.81% | +7.28% | |
Candriam Equities L Biotechnolo... | reinvestment | 820.1800 | +6.87% | +4.67% | |
Candriam Equities L Biotechnolog... | paying dividend | 749.0700 | +6.83% | +4.57% |
Performance
CAD | -0.56% | ||
---|---|---|---|
6 Mois | +17.28% | ||
1 An | +7.81% | ||
3 Ans | +7.28% | ||
5 Ans | +54.90% | ||
Depuis le début | +160.35% | ||
Année | |||
2023 | +8.10% | ||
2022 | -0.72% | ||
2021 | -1.91% | ||
2020 | +20.18% | ||
2019 | +36.03% | ||
2018 | -10.56% | ||
2017 | +27.71% | ||
2016 | -18.88% | ||
2015 | +9.00% |